HDAC11 and breast cancer: In support of decreased HDAC11 within LNs leading to increased RRM2 and distant metastasis, functioning as a “release mechanism,” we found that RRM2 is highly associated with poor disease-free survival in breast cancer, including patients with LN involvement at diagnosis (Fig. 4j, k).